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Development Goals or other campaigns. While facility-
level staff are often urged to ‘improve’ performance, they 
have difficulty assessing quantitatively how their facility 
should contribute to the intended outcome of each strategic 
initiative. The tool uses data that are readily available to 
district managers for the purpose of setting targets, measuring 
progress and optimising resources at each facility.
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CLINICAL IMAGES
Reversible nephrotic syndrome secondary to pulmonary 
hydatid disease
Tahar Gargah, Rim Goucha-Louzir, Youssef Gharbi, Rachid Mohamed Lakhoua
Most patients with pulmonary hydatidosis are children. The 
disease may be asymptomatic or revealed by unusual events 
such as a glomerulopathy.1
Case report
An 8-year-old boy from a rural part of Tunisia presented 
with generalised oedema and macroscopic haematuria. There 
was no familial history of renal disease. He had a normal 
blood pressure (100/60 mmHg), and a pleural effusion was 
detected. Urinalysis showed nephrotic range proteinuria 
(375 mg/kg/d) and microscopic haematuria. His serum total 
protein concentration was 40 g/l and his serum albumin was 
10 g/l. Renal biopsy showed capillary wall thickening and 
duplication, and mesangial cell proliferation in the glomeruli, 
characteristic of mesangiocapillary glomerulonephritis. 
Renal and abdominal ultrasound images showed increased 
echogenicity of the kidneys and mild ascites. Radiology 
revealed three large pulmonary hydatid cysts (Figs 1 and 
2). The largest cyst occupied the entire right upper lobe 
and compressed the superior vena cava. Hydatid disease 
was confirmed by a strongly positive serum enzyme-linked 
immunosorbent assay (ELISA) for echinococcus.
The patient was treated with high protein intake, 
dipyramidol and captopril; both right lung cysts were resected, 
followed by the left pulmonary cyst 4 weeks later. Hydatid 
cyst was confirmed histopathologically. He recovered well, the 
serum ELISA for echinococcus became negative, and follow-
up urine examination and thoracic computerised tomography 
were normal 6 months after surgery, confirming good renal 
recovery and absence of pulmonary hydatid disease.
Discussion
Renal involvement during hydatid disease is well recognised.1 
The most common manifestation is proteinuria, with or 
without nephrotic syndrome. Several histopathological 
types have been demonstrated.1-3 The pathogenesis of 
glomerular disease in patients with hydatid disease is 
not well understood, with most supporting an immune 
complex-mediated mechanism. Echinococcal antigen 
and corresponding antibody in the glomeruli have been 
demonstrated by immunoperoxidase studies.4 The site of 
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Fig. 1. Chest radiograph showing a bilateral well-circumscribed dense 
lesion.
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the hydatid cyst appears to be crucial in the development 
of glomerular damage, since all reported cases are of either 
hepatic or pulmonary location. However, this deduction may 
be unfounded as hydatids occur most frequently in these 
locations.
Renal involvement during hydatid disease is not 
confined to the glomeruli. A case of predominantly chronic 
tubulo-interstitial nephritis with mesangioproliferative 
glomerulonephritis in a patient with hepatic hydatid cyst 
which responded to cyst resection was reported.5 In our 
patient, the lesions were confined to the glomeruli which have 
the typical features of a mesangiocapillary glomerulonephritis. 
Most cases of glomerular lesions associated with hydatid 
disease, including ours, are reversible by medical or surgical 
treatment of the hydatid;3 this demonstrates the causal 
relationship between hydatid disease and glomerulopathy. 
Our observation is believed to be the first in a child in the first 
decade, with renal histological confirmation.
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Fig. 2. CT scan showing  bilateral hydatid cysts of the lungs.
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